Art

J-GLOBAL ID：201302212115536356   Reference number：13A1299189

Structure-Activity Relationship Study and Total Synthesis of Pyripyropene A as a Potent ACAT2-Selective Inhibitor

新規脂質異常症予防治療薬を指向したACAT2選択的阻害剤ピリピロペンAの構造活性相関研究

Author (5)： OTAWA MASAKI (北里大 薬) ,  OMURA SATOSHI (北里大 北里生命科研) ,  TOMODA HIROSHI (北里大 薬) ,  NAGAMITSU TOORU (北里大 薬) ,  NAGAMITSU TOORU (北里大 大学院薬学研究科)
Material： 有機合成化学協会誌  (Journal of Synthetic Organic Chemistry, Japan)
Volume： 71  Issue： 8  Page： 830-843  Publication year： Aug. 01, 2013 
JST Material Number： F0383A  ISSN： 0037-9980  CODEN： YGKKAE  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： sterol O-acyltransferase ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A1299189&from=J-GLOBAL&jstjournalNo=F0383A") }}

JST classification (2)： Synthesis of drugs  (GV01030F) ,  Condensed derivatives of pyrane  (CF07093I)

Substance index (9)： Pyripyropene A ,  6-Oxo-6H-pyran-3-carboxylic acid (3S)-3α-acetoxy-4β-(acetoxymethyl)-11-oxo-1,3,4,4aβ,5,6,6a,12,12aβ,12b-decahydro-12α-hydroxy-4,6aα,12bα-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-6α-yl ester ,  Pyrazine-2-carboxylic acid (3S)-3α-acetoxy-4β-(acetoxymethyl)-11-oxo-1,3,4,4aβ,5,6,6a,12,12aβ,12b-decahydro-12α-hydroxy-4,6aα,12bα-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-6α-yl ester ,  4-Cyanobenzoic acid (3S)-3α,4β-[oxy(di-tert-butylsilylene)oxymethylene]-11-oxo-1,3,4,4aβ,5,6,6a,12,12aβ,12b-decahydro-12α-hydroxy-4,6aα,12bα-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-6α-yl ester ,  4-Cyanobenzoic acid (3S)-3α-(di-tert-butylfluorosilyl)-4β-(hydroxymethyl)-11-oxo-1,3,4,4aβ,5,6,6a,12,12aβ,12b-decahydro-12α-hydroxy-4,6aα,12bα-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-6α-yl ester ,  4-Cyanobenzoic acid (3S)-3α,12α-dihydroxy-4β-[(di-tert-butylfluorosiloxy)methyl]-11-oxo-1,3,4,4aβ,5,6,6a,12,12aβ,12b-decahydro-4,6aα,12bα-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-6α-yl ester ,  4-Cyanobenzoic acid (3S)-3α,12α-dihydroxy-4β-(hydroxymethyl)-11-oxo-1,3,4,4aβ,5,6,6a,12,12aβ,12b-decahydro-4,6aα,12bα-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-6α-yl ester ,  Pentanoic acid (3S)-3α,4β-[oxy[(R)-propane-1,1-diyl]oxymethylene]-11-oxo-1,3,4,4aβ,5,6,6a,12,12aβ,12b-decahydro-12α-hydroxy-4,6aα,12bα-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-6α-yl ester ,  4-Cyanobenzoic acid (3S)-3α,4β-[oxy[(R)-phenylmethylene]oxymethylene]-11-oxo-1,3,4,4aβ,5,6,6a,12,12aβ,12b-decahydro-12α-hydroxy-4,6aα,12bα-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-6α-yl ester

Reference (53)：

• 1) 寺本民夫,生活習慣病,119 (2001)
• 2) K. E. Sucking, E. F. Stange, J. Lipid Res., 26, 647 (1985)
• 3) C. C. Chang, H. Y. Huh, K. M. Cadigan, T. Y. Chang, J. Biol. Chem., 268, 20747 (1993)
• 4) R. A. Anderson, C. Joyce, M. Davis, J. W. Reagan, M. Clark, G. S. Shelness, L. L. Rudel, J. Biol. Chem., 273, 26747 (1998)
• 5) S. Cases, S. Novak, Y. W. Zheng, H. M. Myers, S. R. Lear, E. Sande, C. B. Welch, A. J. Lusis, T. A. Spencer, B. R. Krause, S. K. Erickson, R. V. Farese, Jr., J. Biol. Chem., 273, 16755 (1998)

Terms in the title (7)： 脂質異常症 ,  予防治療 ,  ACAT2 ,  阻害剤 ,  ピリピロペンA ,  構造活性相関 ,  研究